Found 79 Enz. Inhib. hit(s) with all data for entry = 8988 TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 0.440nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 0.520nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 0.540nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 0.570nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 0.580nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 0.600nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 0.620nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 0.630nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 0.700nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 0.730nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 0.770nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 0.850nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 0.850nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 0.850nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 0.910nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 0.910nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 0.950nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 0.960nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 0.960nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 1.01nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 1.06nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 1.08nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 1.15nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 1.22nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 1.22nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 1.25nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 1.45nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 1.5nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 1.51nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 1.53nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 1.62nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 1.68nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 1.76nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 1.80nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 1.84nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 1.91nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 1.97nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 2.07nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 2.15nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 2.16nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 2.16nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 2.21nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 2.23nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 2.34nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 2.68nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 3.09nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 3.39nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 3.48nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 3.49nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
TargetAdenosine receptor A3(Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services; Saint Louis University
US Patent
Affinity DataKi: 3.53nMAssay Description:[3H]R—N6-Phenylisopropyladenosine (40, [3H]R-PIA, 63 Ci/mmol), [3H](2-[p-(2-carboxyethyl)phenyl-ethylamino]-5′-N-ethylcarboxamido-adenosine) (4...More data for this Ligand-Target Pair
